A Study of MK-8527 in Healthy Lactating Female Participants (MK-8527-009)
NCT06580587
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
13
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
HIV Pre-exposure Prophylaxis
Interventions
DRUG:
MK-8527
Sponsor
Merck Sharp & Dohme LLC